Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Human Stage Holdings's Debt-to-EBITDA or its related term are showing as below:
TSE:321A'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: 4.86 Med: 7.34 Max: 12.22
Current: 7.34
During the past 3 years, the highest Debt-to-EBITDA Ratio of Human Stage Holdings was 12.22. The lowest was 4.86. And the median was 7.34.
TSE:321A's Debt-to-EBITDA is not ranked
in the Conglomerates industry.
Industry Median: 2.74
vs TSE:321A: 7.34
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Human Stage Holdings Debt-to-EBITDA Related Terms
Human Stage Holdings Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for Human Stage Holdings's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Human Stage Holdings Debt-to-EBITDA Chart
Human Stage Holdings Annual Data
Trend
Mar24
Mar25
Mar26
Debt-to-EBITDA
4.86
12.22
7.34
Human Stage Holdings Semi-Annual Data
Mar24
Sep24
Mar25
Sep25
Mar26
Debt-to-EBITDA
N/A
4.42
-20.09
4.29
22.33
TSE:321A vs HON, MMM: Debt-to-EBITDA Comparison
For the Conglomerates subindustry, Human Stage Holdings's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Human Stage Holdings Debt-to-EBITDA vs Conglomerates Industry
For the Conglomerates industry and Industrials sector, Human Stage Holdings's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Human Stage Holdings's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is two times the quarterly (Mar. 2026) EBITDA data.
Human Stage Holdings (TSE:321A) has a Debt-to-EBITDA of 22.33 as of Mar. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Human Stage Holdings. This is 204% above median its historical median of 7.34. Over the past decade, Human Stage Holdings' Debt-to-EBITDA has ranged from 4.86 to 12.22.
Is Human Stage Holdings' Debt-to-EBITDA too high?
Human Stage Holdings' current Debt-to-EBITDA of 22.33 is 204% above median its 10-year median of 7.34. Over the past 10 years, this metric has ranged from a low of 4.86 to a high of 12.22. The Conglomerates industry median Debt-to-EBITDA is 2.74. Human Stage Holdings' value of 22.33 is 715% above this industry median. Overall, Human Stage Holdings has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Human Stage Holdings' Debt-to-EBITDA compare to HON and MMM?
Human Stage Holdings' Debt-to-EBITDA of 22.33 can be compared against companies in the Conglomerates industry. The industry median Debt-to-EBITDA is 2.74. Human Stage Holdings' value of 22.33 is 715% above this benchmark. Historically, Human Stage Holdings' own Debt-to-EBITDA has ranged from 4.86 to 12.22 over the past decade. While the company's 10-year median is 7.34 vs. the industry median of 2.74, Human Stage Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Conglomerates company?
The median Debt-to-EBITDA among Conglomerates companies is 2.74, based on 454 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Human Stage Holdings's current Debt-to-EBITDA of 22.33 is 715% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Human Stage Holdings. For the Conglomerates industry, the median Debt-to-EBITDA is 2.74 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Human Stage Holdings's current Debt-to-EBITDA is 22.33, which is 204% above median its own 10-year median of 7.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Human Stage Holdings stock overvalued right now?
Human Stage Holdings (TSE:321A) has a current Debt-to-EBITDA of 22.33. The current Debt-to-EBITDA is 22.33, which is 204% above median its 10-year median of 7.34 and 715% above the Conglomerates industry median of 2.74. Human Stage Holdings' overall GF Score™ is 12/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Human Stage Holdings (TSE:321A), the current Debt-to-EBITDA is 22.33 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Human Stage Holdings Corp is engaged in consulting services related to asset management and operation of group subsidiaries engaged in the temporary staffing business and real estate leasing business.
12GF Score
Get the complete analysis for TSE:321A
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:321A has been successfully added to your 
